Shenzhen Neptunus Interlong Bio-technique Company Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 299.72 million compared to CNY 215.7 million a year ago. Net income was CNY 16.26 million compared to CNY 10.54 million a year ago.

Basic earnings per share from continuing operations was CNY 0.0097 compared to CNY 0.0063 a year ago.